PROGENICS PHARMACEUTICALS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - continued

(amounts in thousands, except per share amounts or as otherwise noted)

5. Fixed Assets

Fixed assets as of December 31, 2014 and 2013 consisted of the following:

	2014			2013
Computer equipment	$	1,784		$	2,234
Machinery and equipment		5,238			7,091
Furniture and fixtures		116			170
Leasehold improvements		5,027			5,020
Other		208			16
		12,373			14,531
Less, accumulated depreciation and amortization		(9,821	)		(12,118	)
Total	$	2,552		$	2,413

At December 31, 2014 and 2013, $1.8 million and $2.0 million, respectively, of leasehold improvements, net were being amortized over periods of 6.4-10.8 years and 8.5-10.8 years, respectively, under leases with terms through December 31, 2020.